MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychogenic movement disorders(PMD): Treatment"

  • 2026 International Congress

    Multidisciplinary Day-Clinic Treatment for Functional Movement Disorders Embedded in a Movement Disorders Center

    P. Krause, J. Reimer, N. Darcy, J. Achtzehn, K. Bereswill, A. Kühn (Berlin, Germany)

    Objective: To evaluate the feasibility and effectiveness of a multimodal day-clinic treatment program for patients with functional movement disorders (FMD) integrated into a neurological movement…
  • 2026 International Congress

    Diagnosis and Treatment of Occult Psychogenic Movement Disorder Without Mood Disorder: A Case Report

    H. Liang, A. Karimova, C. Liang (Almaty, Kazakhstan)

    Objective: This case report describes a 17-year-old female with occult psychogenic movement disorder (PMD) presenting with involuntary tremor and abnormal somatic movement as core symptoms,…
  • 2026 International Congress

    Functional Movement Disorders in Older Adults in Latin America: A Narrative Literature Review

    M. Bonilla-Arbeláez, M. Wongpaiboon, J. Urrea-Perez, A. Ramirez-Zamora, E. Urrea-Mendoza (Caldas, Colombia)

    Objective: To review the available literature on FMD in older adults (aged ≥ 65 years) in Latin America, focusing on epidemiology, clinical features, diagnostic challenges, treatment, and…
  • 2026 International Congress

    Closed-Loop Acoustic Neuromodulation for Functional Movement Disorder

    B. Dukes, C. Tegeler, C. Tegeler, H. Munger Clary, K. Brown, M. Thenganatt, H. Shaltout, D. Shah-Zamora (Winston-Salem, USA)

    Objective: Evaluate the effect of acoustic neuromodulation (AN) on people with functional movement disorder (FMD). Background: FMD, characterized by involuntary, unwanted movements that can be disabling, is associated with dysregulated autonomic,…
  • 2026 International Congress

    Nocturnal Blood Pressure Non-Dipping as an Autonomic Biomarker of Psychosis and Movement Disorder Severity in Pediatric Epilepsy

    S. Sharma, V. Sharma, P. Maheshwari (Agra, India)

    Objective: To investigate the association between 24-hour ambulatory blood pressure monitoring (ABPM) patterns, particularly nocturnal non-dipping, and psychosis severity, movement disorder burden, and non-motor symptoms…
  • 2025 International Congress

    Mind-Body Treatment For Managing Functional Weakness: A Pilot Study

    L. Tesolin, S. Calizaya, M. Lobos, M. Villar (Bolzano, Italy)

    Objective: This study evaluates the effectiveness of a group-based, treatment combining yoga, reflexotherapy, and biodanza for patients diagnosed with FMD, characterized by weakness (1). Background:…
  • 2024 International Congress

    EEG Profiles in People with Functional Movement Disorders Before and After a Single Bout of Hatha Yoga and Moderate-vigorous Intensity Aerobic Exercise: A Protocol for a Pilot Feasibility Study

    D. Kipnis, P. Smith, S. Leung, M. Bjalme-Evan, A. Nesru, C. Amlang, H. Shah, K. Froud, L. Quinn (New York, USA)

    Objective: To observe neural responses to movement among people with Functional Movement Disorder (PwFMD) versus age-matched controls by assessing event-related brain potentials (ERPs) related to…
  • 2024 International Congress

    Outpatient Treatment of Functional Movement Disorders

    D. Hinkle, S. Patel, A. Husted, B. Darrah, B. Bettonville, C. Sabbagh (Columbus, USA)

    Objective: To assess the capacity of an outpatient-based functional movement disorders (FMD) treatment program to reduce FMD symptoms. Background: FMDs are common, intrusive, and systemically…
  • 2024 International Congress

    Creating a Multi-institutional, Interdisciplinary Functional Neurological Disorder (FND) Clinic in an Urban Setting

    D. Kipnis, Z. Grin, S. Leung, Z. L'Erario, C. Amlang (New York, USA)

    Objective: To describe the process to create an interdisciplinary FND clinic with independent practitioners in the New York City area. Background: Estimated 9,000 people in…
  • 2024 International Congress

    Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population

    M. Verduzco-Gutierrez, A. Keener, I. Howard, D. Torres-Russotto, J. Sparrow, R. Kazerooni (San Antonio, USA)

    Objective: To examine the disparities in utilization of botulinum toxin (BoNT) injections for patients with cervical dystonia (CD) within the United States Medicare population. Background:…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley